SCHEMBL23627552

SCHEMBL23627552

CCCCCCC(C)(CCCC)[C@H](N)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.41
CYP2D6 P10635 4/20 0.41
MAPT P10636 4/20 0.41
SPHK1 Q9NYA1 4/20 0.41
GMNN O75496 3/20 0.41
POLB P06746 3/20 0.41
BLM P54132 3/20 0.41
CETP P11597 3/20 0.41
UBE2N P61088 3/20 0.41
THPO P40225 2/20 0.41
TP53 P04637 2/20 0.41
CYP1A2 P05177 2/20 0.41
MTOR P42345 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
HTT P42858 1/20 0.41
FDPS P14324 3/20 0.37
SMPD1 P17405 2/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23627333 1.00 LMNA (0.41) LMNACYP2D6MAPTSPHK1GMNN
SCHEMBL22096924 0.98 LMNA (0.38) LMNACYP2D6MAPTSPHK1GMNN
SCHEMBL23436516 0.98 LMNA (0.42) LMNACYP2D6MAPTSPHK1GMNN
SCHEMBL23436525 0.82 LMNA (0.42) LMNACYP2D6MAPTSPHK1GMNN
SCHEMBL2332834 0.81 FDPS (0.36) SPHK1FDPSSMPD1MEN1KMT2A
Hydrochloric Acid SCHEMBL4386616 0.79 DNM1 (0.37) SPHK1FDPSSMPD1MEN1KMT2A
SCHEMBL16649028 0.79 OPRM1 (0.37) SPHK1FDPSSMPD1MEN1KMT2A
SCHEMBL19274582 0.78 OPRM1 (0.35) SPHK1FDPSSMPD1THRBMAPK1
SCHEMBL23627348 0.78 LMNA (0.40) LMNACYP2D6MAPTSPHK1GMNN
Water SCHEMBL7554274 0.78 OPRM1 (0.43) LMNACYP2D6MAPTSPHK1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205463-A1 STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES PFIZER INC. (US) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205463-A1 STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES FCGR2A, FCGRT, FCGR1A LMNA 3839/4885CYP2D6 3416/4885MAPT 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.